The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2020
Filed:
Nov. 08, 2017
Applicant:
Occurx Pty Ltd, Melbourne, AU;
Inventors:
Darren James Kelly, Wonga Park, AU;
David Stapleton, Warrandyte, AU;
Assignee:
Occurx Pty Ltd, Melbourne, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/167 (2006.01); A61K 9/00 (2006.01); A61K 31/5375 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/4192 (2006.01); A61K 31/42 (2006.01); A61K 31/4425 (2006.01); A61K 31/5377 (2006.01); A61K 31/4412 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5375 (2013.01); A61K 9/0048 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/4192 (2013.01); A61K 31/42 (2013.01); A61K 31/4412 (2013.01); A61K 31/4425 (2013.01); A61K 31/5377 (2013.01); Y10S 514/914 (2013.01);
Abstract
Methods for treating eye diseases associated with inflammation and/or vascular proliferation in subjects are disclosed. The methods include administering therapeutically effective amounts of a tranilast compound, in particular (E)-2-[[3-(3-Methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or (E)-2-[[3,4-Bis(difluoromethoxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid or pharmaceutically acceptable salts or solvates thereof.